Senior Medical Director, Clinical Development, Obesity
Regeneron Pharmaceuticals
About this role
Senior Medical Director, Clinical Development provides medical and scientific leadership for the Internal Medicine portfolio focused on obesity and related comorbidities. The role acts as the scientific/medical lead for clinical teams, partnering with operational leads and reporting to the Executive Medical Director to support clinical development and regulatory activities.
Skills
Qualifications
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Recent company news
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
7 hours ago
About Regeneron Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Salary
$328k – $444k
per year
More jobs at Regeneron Pharmaceuticals
Similar Jobs
Executive Medical Director, Obesity
Amgen
Clinical Development Medical Director
Diversity Employment
Clinical Development Associate Medical Director- Pain
Vertex
Global Medical Head, Obesity
AstraZeneca
Clinical Development Medical Director
Novartis
Executive Medical Director, Clinical Development
Eli Lilly and Company